Prelude Therapeutics, Inc. (PRLD)

2.17 +0.15 (+7.43%) USD  |  NASDAQ  |  Feb 06, 16:00
2.18 +0.01 (+0.46%) After-Hours: 20:00
More

Prelude Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for PRLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
BioLife Solutions, Inc. Upgrade
Immunome, Inc. Upgrade
Incyte Corp. Upgrade
Aclaris Therapeutics, Inc. Upgrade
Relay Therapeutics, Inc. Upgrade